Program Types
Medication-Assisted Treatment (MAT) in New Jersey
Medication for opioid or alcohol use disorder — buprenorphine, methadone, or naltrexone — is an individualized clinical decision made with a licensed prescriber, often alongside counseling or other support. Here's what the terms mean and how to evaluate access in New Jersey.
Published: · Last updated: · 11 min read · By Christopher Veto, NCACIP

What MAT actually involves
Medication-assisted treatment, now often labeled medications for opioid use disorder (MOUD) in the opioid context, pairs an FDA-approved medicine with counseling and behavioral support whenever that combination suits the person's plan. Plenty of people benefit from counseling, but it isn't required before medication can start \u2014 the choice of whether to begin, which medicine to use, and what support wraps around it are clinical calls made between a patient and a licensed prescriber. The National Institute on Drug Abuse identifies methadone, buprenorphine, and naltrexone as the medications most often used for opioid use disorder, with naltrexone doing double duty as an approved treatment for alcohol use disorder.
One persistent myth frames MAT as trading one addiction for another. Federal research pushes back on that framing fairly directly: these medicines act differently than the substances someone may have used before, and buprenorphine and methadone in particular ease cravings and withdrawal without the same euphoric intensity when taken as directed. None of that tells any one person what they should take \u2014 that call rests with a licensed prescriber assessing an individual case.
The three medications, explained without bias
Methadone is a full opioid agonist that engages the same receptors as other opioids, but in a carefully controlled dose handed out through a licensed program. Buprenorphine, a partial agonist, activates those receptors more mildly and can also block other opioids from binding \u2014 one reason it's allowed in office-based settings with lighter restrictions than methadone carries. Naltrexone works oppositely as an antagonist, blocking the receptors instead of triggering them, and that mechanism is also why it's approved for alcohol use disorder.
No single medicine suits everyone equally, and picking among them \u2014 or deciding none applies \u2014 is a clinical judgment a prescriber makes using someone's medical history, current medications, and personal circumstances, not something a general page can decide for them.
Suboxone, Sublocade, and Brixadi: buprenorphine under different brand names
Buprenorphine shows up in searches under several brand names. All of these products share the same active ingredient but differ in how they're delivered. A licensed prescriber is the right person to weigh in on which, if any, fits.
Suboxone and generic buprenorphine/naloxone
Suboxone dissolves under the tongue or against the cheek and pairs buprenorphine with naloxone, added specifically to deter injection misuse. Generic versions of this combination, in both film and tablet form, are widely sold too. These are typically taken once a day and picked up like any other prescription. Because starting buprenorphine too close to other opioid use can trigger sudden withdrawal, prescribers time that first dose carefully \u2014 fentanyl use can complicate that timing further.
Sublocade (monthly injection)
Sublocade delivers extended-release buprenorphine under the skin once a month. The FDA approved it in 2017 for people already stabilized on at least seven days of oral or sublingual buprenorphine. A healthcare provider must administer it in a clinical setting \u2014 it's not something patients take home.
Brixadi (weekly or monthly injection)
Brixadi, an extended-release buprenorphine shot approved by the FDA in 2023, comes in both weekly and monthly formulations, giving prescribers more scheduling flexibility. Per the FDA, it can be started in patients already on buprenorphine or after a single sublingual test dose. Like Sublocade, a provider gives the injection rather than sending it home with the patient.
Comparing the options quickly
- Suboxone / generic films or tablets: daily buprenorphine, usually self-administered at home after a pharmacy pickup.
- Sublocade: monthly buprenorphine injection at a provider's office, available once someone is stable on daily buprenorphine.
- Brixadi: weekly or monthly buprenorphine injection given in an office setting.
- Vivitrol: monthly naltrexone injection, requiring an opioid-free period beforehand.
- Methadone: dispensed through a certified opioid treatment program, usually daily early on.
Going the injectable route can cut down on missed doses and remove medication from the home entirely. Daily films, on the other hand, are simpler to adjust on the fly. Cost, insurance, and how easily someone can reach an office all factor in too \u2014 worth working through with a prescriber.
Questions worth raising about injectable buprenorphine
- Can this prescriber or clinic provide Sublocade, Brixadi, or both?
- What needs to be done before the first dose is given?
- Will my insurer want prior authorization, and whose job is it to file that?
- Does the pharmacy or the office handle billing, and what will I be charged?
- What's the policy if an appointment gets missed?
NJ FamilyCare and most commercial plans in New Jersey include buprenorphine coverage, though the specifics shift by product and plan. For questions to bring to an insurer, see NJ FamilyCare coverage for addiction treatment and the guide to paying for detox in New Jersey . When opioid withdrawal needs managing before MAT begins, see opioid and fentanyl detox in New Jersey.
OTPs versus office-based prescribers
Only a federally certified opioid treatment program (OTP) may dispense methadone, which usually means daily or near-daily visits at the start, alongside counseling and other support services the OTP provides. Buprenorphine, by contrast, can be prescribed by qualified physicians, nurse practitioners, or physician assistants outside a clinic setting, usually meaning fewer in-person visits and more flexibility \u2014 including options through primary care or telehealth. Naltrexone, whether oral or the extended-release Vivitrol shot, is typically managed by an office-based prescriber as well.
SAMHSA has loosened some OTP rules in recent years, particularly around take-home methadone doses, so a specific program's current visit schedule is worth asking about rather than assuming daily attendance is mandatory \u2014 older descriptions of the rules may no longer apply.
Myths worth double-checking
A handful of claims circulate often enough that naming them directly \u2014 and pointing toward where the actual research lives \u2014 is more useful than letting them pass unchallenged.
- "MAT is just another addiction" \u2014 federal agencies describe these medicines as functioning differently from the substances someone used before, especially regarding euphoria, when taken as prescribed; a prescriber can walk through specifics for the medication under discussion.
- "Being on MAT means you're not truly in recovery" \u2014 that's a values-based opinion some people and programs hold, not a clinical or legal benchmark, and views on it vary across programs and support communities.
- "Once you start, you're on it forever" \u2014 how long treatment lasts varies by person and gets decided over time between patient and prescriber, not by a blanket rule.
- "Any doctor can prescribe methadone" \u2014 methadone for addiction treatment must come through a certified OTP, unlike methadone prescribed for pain management by other providers.
Questions for a prescriber or program
Since medication choice, dosage, and treatment length are all individualized, these questions belong in a conversation with a licensed prescriber rather than with a general resource.
- Out of the medications this program or prescriber offers, what makes one a better fit than another here?
- How often will visits happen early on, and when does that schedule typically loosen up?
- Is counseling bundled in with the medication, or is it optional on top of it?
- If someone eventually wants to come off the medication, what does that tapering process look like?
Finding access in New Jersey
Across the state, both OTPs and office-based buprenorphine or naltrexone prescribers operate, and the state's Division of Mental Health and Addiction Services is a reasonable place to start learning about publicly funded options. Since availability, wait times, and insurance acceptance shift over time, the surest path is confirming directly with a program or using SAMHSA's national treatment locator, which lets users filter specifically for MAT and OTP services.
Jersey City Detox Support Services doesn't prescribe, dispense, or verify insurance for any medication or program. What a call here can do is help someone sort through what they're looking for and point toward verifiable resources \u2014 any facility or prescriber under consideration should still be confirmed independently.
Frequently Asked Questions
Is methadone or buprenorphine better?
There's no across-the-board winner — what fits best hinges on a person's health background, circumstances, and goals, which is a conversation for a licensed prescriber rather than something a general website can settle.
Can I get buprenorphine from my regular doctor?
It depends on whether that doctor is qualified to prescribe buprenorphine. The simplest route is to ask them directly or request a referral to someone who can.
Do I have to go to a clinic every day for MAT?
It depends which medication is involved. Methadone comes through opioid treatment programs and can mean frequent early visits, though take-home allowances have grown more flexible. Buprenorphine usually involves far fewer office visits.
Is naltrexone addictive?
As an opioid antagonist, naltrexone doesn't trigger the reward response that opioids do, which separates it from methadone and buprenorphine in that respect. A prescriber can speak to how that applies to your situation.
Does this organization prescribe MAT?
No. Jersey City Detox Support Services is an independent information and referral resource. It does not prescribe, dispense, or administer any medication.
Will insurance cover MAT in New Jersey?
It depends on the plan. Check directly with both the insurer and the specific program or prescriber, and get the answer in writing rather than taking coverage for granted.
What is the difference between Suboxone, Sublocade, and Brixadi?
Buprenorphine is the active ingredient in all three. Suboxone, a daily under-the-tongue film, also contains naloxone. Sublocade is injected once monthly, and Brixadi is injected weekly or monthly, with a provider administering both. A prescriber helps determine which option makes sense.
Can I take Sublocade or Brixadi at home?
No. A healthcare provider administers both injections in a clinical setting; neither is sent home with patients.
Sources
Last reviewed: October 6, 2026
- FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder (Brixadi) — U.S. Food and Drug Administration
- Sublocade (buprenorphine extended-release) NDA approval letter — U.S. Food and Drug Administration
- Information about Medications for Opioid Use Disorder — U.S. Food and Drug Administration
- Medications for Opioid Use Disorder — National Institute on Drug Abuse
- Naltrexone Treatment — National Institute on Alcohol Abuse and Alcoholism
- Opioid Treatment Program Information for Providers — SAMHSA
- Methadone Take-Home Flexibility Guidance for Opioid Treatment Programs — SAMHSA
- Division of Mental Health and Addiction Services — NJ Department of Human Services
- FindTreatment.gov — SAMHSA's treatment locator
Related Resources
- Signs of Opioid Addiction: When to Seek Help
What often shows up before someone starts exploring medication treatment.
- Opioid and Fentanyl Detox Programs in New Jersey
A look at medical opioid detox and how it leads into ongoing MAT.
- Outpatient Rehab, IOP & PHP Programs in New Jersey
MAT is often paired with outpatient counseling — here's how that level of care functions.
- Dual Diagnosis & Co-Occurring Mental Health Treatment in New Jersey
Useful for anyone navigating both a substance use disorder and a mental health condition while on MAT.
- How to Choose a Treatment Program
A wider set of questions for evaluating any program, MAT-focused or not.
Questions About Next Steps?
Call for general treatment information and referral support. We can help you prepare questions to ask independently operated providers.